Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy-Reference-Cited by-同舟云学术

Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes considered for injectable GLP-1 receptor agonist therapy or currently on insulin therapy

Published:2020-09-08 Issue:sup2 Volume:132 Page:26-36
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Wright Jr Eugene E.¹^ORCID,Aroda Vanita R.²^ORCID

Affiliation:

1. Charlotte Area Health Education Center, Charlotte, NC, USA

2. Brigham and Women’s Hospital; Harvard Medical School, Boston, MA, USA

Funder

company was provided with the opportunity to perform a medical accuracy review

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1798127

Reference50 articles.

1. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

2. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

3. Insulin Therapy for Type 2 Diabetes Mellitus

4. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials

5. Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel;Diabetes Therapy;2024-07-22

2. SIBUTRAMINA E LIRAGLUTIDA NA TERAPÊUTICA DA OBESIDADE;Revista Contemporânea;2024-04-22

3. Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides;Pharmaceutics;2022-12-15

4. Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-06

5. Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24;Proceedings of the National Academy of Sciences;2022-05-13